Seastar Medical Holding CORP Form 4 insider transactions
NASDAQ
Director Jennifer A. Baird acquired 8,000 restricted stock units in SeaStar Medical Holding Corp on November 13, 2024.
NASDAQ
Director Bernadette N. Vincent of SeaStar Medical Holding Corp. received 8,000 restricted stock units (RSUs) on November 13, 2024, which will vest over three years.
NASDAQ
SeaStar Medical's Chief Medical Officer, Kevin Chung, acquired 4,250 shares of common stock and 15,000 restricted stock units.
NASDAQ
SeaStar Medical's CEO, Eric Schlorff, was granted 65,000 restricted stock units (RSUs) that vest over three years.
NASDAQ
Director Rick Barnett of SeaStar Medical Holding Corp acquired 4,000 restricted stock units on November 13, 2024, which will vest on June 4, 2025.
NASDAQ
SeaStar Medical Holding Corp director Kenneth Van Heel acquired 4,000 restricted stock units on November 13, 2024, which will vest on June 4, 2025.
NASDAQ
Director John Neuman of SeaStar Medical Holding Corp acquired 8,000 restricted stock units on November 13, 2024.
NASDAQ
Director Allan Collins of SeaStar Medical Holding Corp. acquired 4,000 restricted stock units on November 13, 2024, which will vest on June 4, 2025.
NASDAQ
Kevin Chung, Chief Medical Officer of SeaStar Medical Holding Corp, recently purchased 1,000 shares of common stock at a price of $4.2581 per share.
NASDAQ
David A. Green, CFO of SeaStar Medical Holding Corp, reports acquiring additional shares of common stock through grants.
NASDAQ
SeaStar Medical's CFO, David A. Green, files an amended SEC Form 4 to correct the number of restricted stock units (RSUs) granted, attributing the error to an administrative oversight.
NASDAQ
David A. Green, CFO of SeaStar Medical Holding Corp, reports the acquisition of 752,500 shares of common stock through restricted stock units.
NASDAQ
Director Richard D. Russell acquires 32,322 shares of SeaStar Medical Holding Corp in lieu of cash fees for services as a director.
NASDAQ
Director Andres Lobo acquired 32,322 shares of SeaStar Medical Holding Corp common stock in lieu of cash fees for director services on April 12, 2024.
NASDAQ
Director Rick Barnett of SeaStar Medical Holding Corp acquires 70,264 shares of common stock in lieu of cash fees for his services.
NASDAQ
Director Kenneth Van Heel acquired 43,564 shares of SeaStar Medical Holding Corp common stock in lieu of cash fees for his services as a director.
NASDAQ
Director Allan Collins received 37,943 shares of SeaStar Medical Holding Corp common stock in lieu of cash fees for his services as a director.
NASDAQ
Director Bruce M. Rodgers receives 36,537 shares of SeaStar Medical Holding Corp common stock in lieu of cash fees for director services.